These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23065710)

  • 1. Alternative splicing of in-frame exon associated with premature termination codons: implications for readthrough therapies.
    Hinzpeter A; Aissat A; de Becdelièvre A; Bieth E; Sondo E; Martin N; Costes B; Costa C; Goossens M; Galietta LJ; Girodon E; Fanen P
    Hum Mutat; 2013 Feb; 34(2):287-91. PubMed ID: 23065710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin.
    Linde L; Boelz S; Nissim-Rafinia M; Oren YS; Wilschanski M; Yaacov Y; Virgilis D; Neu-Yilik G; Kulozik AE; Kerem E; Kerem B
    J Clin Invest; 2007 Mar; 117(3):683-92. PubMed ID: 17290305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exon skipping through the creation of a putative exonic splicing silencer as a consequence of the cystic fibrosis mutation R553X.
    Aznarez I; Zielenski J; Rommens JM; Blencowe BJ; Tsui LC
    J Med Genet; 2007 May; 44(5):341-6. PubMed ID: 17475917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Missense, nonsense, and neutral mutations define juxtaposed regulatory elements of splicing in cystic fibrosis transmembrane regulator exon 9.
    Pagani F; Buratti E; Stuani C; Baralle FE
    J Biol Chem; 2003 Jul; 278(29):26580-8. PubMed ID: 12732620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The suppression of premature termination codons and the repair of splicing mutations in CFTR.
    Oren YS; Pranke IM; Kerem B; Sermet-Gaudelus I
    Curr Opin Pharmacol; 2017 Jun; 34():125-131. PubMed ID: 29128743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of premature stop codon readthrough in the CFTR gene by Ataluren (PTC124) derivatives.
    Pibiri I; Lentini L; Melfi R; Gallucci G; Pace A; Spinello A; Barone G; Di Leonardo A
    Eur J Med Chem; 2015 Aug; 101():236-44. PubMed ID: 26142488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonsense-mediated mRNA decay and cystic fibrosis.
    Linde L; Kerem B
    Methods Mol Biol; 2011; 741():137-54. PubMed ID: 21594783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy.
    Kerem E
    Pediatr Pulmonol; 2005 Sep; 40(3):183-96. PubMed ID: 15880796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open reading frame correction using splice-switching antisense oligonucleotides for the treatment of cystic fibrosis.
    Michaels WE; Pena-Rasgado C; Kotaria R; Bridges RJ; Hastings ML
    Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35017302
    [No Abstract]   [Full Text] [Related]  

  • 10. Nonsense-associated altered splicing: a frame-dependent response distinct from nonsense-mediated decay.
    Wang J; Chang YF; Hamilton JI; Wilkinson MF
    Mol Cell; 2002 Oct; 10(4):951-7. PubMed ID: 12419238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introducing sense into nonsense in treatments of human genetic diseases.
    Linde L; Kerem B
    Trends Genet; 2008 Nov; 24(11):552-63. PubMed ID: 18937996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes.
    Liu HX; Cartegni L; Zhang MQ; Krainer AR
    Nat Genet; 2001 Jan; 27(1):55-8. PubMed ID: 11137998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of premature termination codon mutations on CFTR mRNA abundance in human nasal epithelium and intestinal organoids: a basis for read-through therapies in cystic fibrosis.
    Clarke LA; Awatade NT; Felício VM; Silva IA; Calucho M; Pereira L; Azevedo P; Cavaco J; Barreto C; Bertuzzo C; Gartner S; Beekman J; Amaral MD
    Hum Mutat; 2019 Mar; 40(3):326-334. PubMed ID: 30488522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative splicing induced by nonsense mutations in the immunoglobulin mu VDJ exon is independent of truncation of the open reading frame.
    Bühler M; Mühlemann O
    RNA; 2005 Feb; 11(2):139-46. PubMed ID: 15613538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative and quantitative analysis of mRNA associated with four putative splicing mutations (621+3A-->G, 2751+2T-->A, 296+1G-->C, 1717-9T-->C-D565G) and one nonsense mutation (E822X) in the CFTR gene.
    Tzetis M; Efthymiadou A; Doudounakis S; Kanavakis E
    Hum Genet; 2001 Dec; 109(6):592-601. PubMed ID: 11810271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of common single-nucleotide polymorphisms on exon 9 and exon 12 skipping in nonmutated CFTR alleles.
    Steiner B; Truninger K; Sanz J; Schaller A; Gallati S
    Hum Mutat; 2004 Aug; 24(2):120-9. PubMed ID: 15241793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative splicing and nonsense-mediated mRNA decay in the regulation of a new adenomatous polyposis coli transcript.
    De Rosa M; Morelli G; Cesaro E; Duraturo F; Turano M; Rossi GB; Delrio P; Izzo P
    Gene; 2007 Jun; 395(1-2):8-14. PubMed ID: 17360132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Clinically Approved Agents That Promote Suppression of Cystic Fibrosis Transmembrane Conductance Regulator Nonsense Mutations.
    Mutyam V; Du M; Xue X; Keeling KM; White EL; Bostwick JR; Rasmussen L; Liu B; Mazur M; Hong JS; Falk Libby E; Liang F; Shang H; Mense M; Suto MJ; Bedwell DM; Rowe SM
    Am J Respir Crit Care Med; 2016 Nov; 194(9):1092-1103. PubMed ID: 27104944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy.
    Howard MT; Shirts BH; Petros LM; Flanigan KM; Gesteland RF; Atkins JF
    Ann Neurol; 2000 Aug; 48(2):164-9. PubMed ID: 10939566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward a rationale for the PTC124 (Ataluren) promoted readthrough of premature stop codons: a computational approach and GFP-reporter cell-based assay.
    Lentini L; Melfi R; Di Leonardo A; Spinello A; Barone G; Pace A; Palumbo Piccionello A; Pibiri I
    Mol Pharm; 2014 Mar; 11(3):653-64. PubMed ID: 24483936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.